Skip to content
GeoClinicalTrials
Back to search

NCT06417710Recruiting

Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis

Official recordSimplified version

Summary

The goal of this project is to develop and validate a reproducible scorecard for the neurological assessment of patients with leptomeningeal metastases that can be used in clinical trials including such patients, as well as in clinical practice.

Inclusion criteria

• Adult patients (18 years or more), female or male • Histologically confirmed diagnosis of extra-CNS primary solid cancer • Diagnosis of leptomeningeal metastases confirmed or probable per EANO ESMO criteria • Performance status compatible with enrolment into clinical trials • Ability to consent • Signed informed consent form from patient • Participation in a parallel clinical trial is allowed in this non-interventional study

Exclusion criteria

• Inability to give informed consent • Inability to adhere to recommended follow-up according to the treating physician Vulnerable participants will not be included.

Contacts

The trial team's contact details are shown on request.

See the official trial record
Status
Recruiting
Phase
—
Study type
Observational
Countries
Switzerland, United States, Netherlands
Sponsor
University of Zurich(Other)
Protocol no.
NANO-LM-01
Conditions
Leptomeningeal Metastasis, Leptomeningeal Disease, Leptomeningeal Neoplasms, Leptomeningeal Cancer
Interventions
Other

Treatments studied

  • Neurological Assessment

Collaborators

M.D. Anderson Cancer Center, The Netherlands Cancer Institute

Locations · 3

  • Zurich, SwitzerlandUniversity Hospital ZurichRecruiting at this site
  • Houston, United StatesMD Anderson Cancer CenterRecruiting at this site
  • Amsterdam, NetherlandsNetherlands Cancer InstituteRecruiting at this site

In total, worldwide, all 3 sites listed in the registry are recruiting.

Site status per the ClinicalTrials.gov registry (last update posted: May 16, 2024).

This status may have changed and says nothing about your eligibility: before taking any step, check with your oncologist or the site.

See also

Other versions

These results are indicative and do not replace medical advice — discuss them with your doctor.